completed at-home clinical lab tests. The reimbursement structure shall be tiered on shipping based upon the nature of the collection and processing needs, for example cold chain requirements, time sensitively, and other infectious disease protocols. (g) Beneficiary costs No provision in this section shall impact the coinsurance applied to beneficiaries as currently reimbursed for clinical laboratory tests. 6. Expanding advanced diagnostic imaging in the home (a) General The Secretary shall conduct an evaluation of Medicare reimbursable advanced diagnostic imaging as defined in subsection (e)(1)(B) of section 1834 of the Social Security Act. The purpose of the evaluation shall be to consider expansions to reimbursable at-home advanced diagnostic imaging services, including costs of transportation. (b) Minimum action At a minimum, the Secretary shall permit the delivery and reimbursement of ultrasound imaging in the home, including the cost of transportation. (c) Eligibility The Secretary shall determine the screening tool or utilization management that would trigger beneficiary eligibility for at-home advanced diagnostic services. Eligibility shall be more comprehensive than the homebound status as defined in sections 1835(a) and 1814(a) of the Social Security Act. The screening tool shall consider other criteria such as chronic conditions, social needs, barriers to accessing care, income level, or dual eligible status. (d) Authority The Secretary shall have the authority to expand the types of at-home advanced diagnostic imaging services reimbursable under Medicare, if medically appropriate and safe. (e) Payment No provision in this section shall impact the payment rates set annually through the physician fee schedule. (f) Report to congress The Secretary shall submit the findings from the evaluation in section (a) in a report to Congress not later than 90 days after enacted. The report should provide justification for the Secretary’s decision not to expand particular diagnostic services in the home and